Research into therapies for Alzheimer’s disease and dementia is progressing, and one day soon, those who are diagnosed early enough may be able to delay onset of the disease for so long that they never experience symptoms. So what’s happening at the forefront of Alzheimer’s research? What are the latest therapies, and how are doctors getting better at diagnosing it? What can we all do to reduce the risk of Alzheimer’s? Medcan senior medical consultant Dr. Lorne Greenspan checks in with clinical director of genetics Jessica Gu and Dr. Sharon Cohen of the Toronto Memory Program, a global expert on the disease (pictured above).